Literature DB >> 22587745

Worsening renal function and prognosis in pulmonary hypertension patients hospitalized for right heart failure.

Lisa M Mielniczuk1, George Chandy, Duncan Stewart, Vladamir Contreras-Dominguez, Haissam Haddad, C Pugliese, Ross A Davies.   

Abstract

Increased central venous pressures have been associated with the development of worsening renal function (WRF), an important marker of prognosis. We sought to determine the incidence and prognostic significance of WRF in pulmonary hypertension patients (PH) with isolated right HF. A prospective study of PH clinic patients admitted to hospital for right HF. WRF was defined as a rise in creatinine of 26 μmol/L (0.3 mg/dL) within the first 48 hours of admission. A total of 32 patients were enrolled in this study, 67% of patients had moderate-severe chronic kidney disease with an eGFR ≤ 60 mL/min and 34% (n=11) developed WRF during their admission. The mean right atrial pressure was higher in patients with WRF (19 ± 7 mm Hg vs 12 ± 6 mm Hg, P=.05). A total of 36% of patients with WRF died in hospital compared to 5% in the group that did not develop WRF (OR for hospital death 13.3 ± 16, P=.03). The combined endpoint of death or readmission at 6 months was 45% in the WRF group and 43% in the group without WRF (P=.89). Significant renal dysfunction is common in patients with PH and an acute decline in renal function is an important marker of in hospital death and short term mortality in right heart failure.
© 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22587745     DOI: 10.1111/j.1751-7133.2011.00275.x

Source DB:  PubMed          Journal:  Congest Heart Fail        ISSN: 1527-5299


  13 in total

1.  Assessment of the effects of hepatic impairment and smoking on the pharmacokinetics of a single oral dose of the soluble guanylate cyclase stimulator riociguat (BAY 63-2521).

Authors:  Reiner Frey; Corina Becker; Sigrun Unger; Anja Schmidt; Georg Wensing; Wolfgang Mück
Journal:  Pulm Circ       Date:  2016-03       Impact factor: 3.017

2.  Trends in pediatric pulmonary hypertension-related hospitalizations in the United States from 2000-2009.

Authors:  David B Frank; Matthew A Crystal; David L S Morales; Ken Gerald; Brian D Hanna; George B Mallory; Joseph W Rossano
Journal:  Pulm Circ       Date:  2015-06       Impact factor: 3.017

3.  Galectin-3 levels are associated with right ventricular functional and morphologic changes in pulmonary arterial hypertension.

Authors:  Brett E Fenster; Luis Lasalvia; Joyce D Schroeder; Jamey Smyser; Lori J Silveira; J Kern Buckner; Kevin K Brown
Journal:  Heart Vessels       Date:  2015-05-15       Impact factor: 2.037

Review 4.  Cardiorenal syndrome in heart failure with preserved ejection fraction-an under-recognized clinical entity.

Authors:  Akanksha Agrawal; Mario Naranjo; Napatt Kanjanahattakij; Janani Rangaswami; Shuchita Gupta
Journal:  Heart Fail Rev       Date:  2019-07       Impact factor: 4.214

Review 5.  Acute Kidney Injury in Cardiorenal Syndrome Type 1 Patients: A Systematic Review and Meta-Analysis.

Authors:  Wim Vandenberghe; Sofie Gevaert; John A Kellum; Sean M Bagshaw; Harlinde Peperstraete; Ingrid Herck; Johan Decruyenaere; Eric A J Hoste
Journal:  Cardiorenal Med       Date:  2015-12-19       Impact factor: 2.041

6.  Left atrial diameter and survival among renal allograft recipients.

Authors:  Alexander Kainz; Georg Goliasch; Franz Wiesbauer; Thomas Binder; Gerald Maurer; Hans-Joachim Nesser; Regina Mascherbauer; Christian Ebner; Reinhard Kramar; Julia Wilflingseder; Rainer Oberbauer
Journal:  Clin J Am Soc Nephrol       Date:  2013-09-05       Impact factor: 8.237

7.  Prevalence, Predictors, and Outcomes of Pulmonary Hypertension in CKD.

Authors:  Sankar D Navaneethan; Jason Roy; Kelvin Tao; Carolyn S Brecklin; Jing Chen; Rajat Deo; John M Flack; Akinlolu O Ojo; Theodore J Plappert; Dominic S Raj; Ghulam Saydain; James H Sondheimer; Ruchi Sood; Susan P Steigerwalt; Raymond R Townsend; Raed A Dweik; Mahboob Rahman
Journal:  J Am Soc Nephrol       Date:  2015-09-18       Impact factor: 10.121

8.  Local and systemic renin-angiotensin system participates in cardiopulmonary-renal interactions in monocrotaline-induced pulmonary hypertension in the rat.

Authors:  Eva Malikova; Kristina Galkova; Peter Vavrinec; Diana Vavrincova-Yaghi; Zuzana Kmecova; Peter Krenek; Jan Klimas
Journal:  Mol Cell Biochem       Date:  2016-06-25       Impact factor: 3.396

9.  N-terminal pro-brain natriuretic peptide is a useful prognostic marker in patients with pre-capillary pulmonary hypertension and renal insufficiency.

Authors:  Lars Harbaum; Jan K Hennigs; Hans J Baumann; Nicole Lüneburg; Elisabeth Griesch; Carsten Bokemeyer; Ekkehard Grünig; Hans Klose
Journal:  PLoS One       Date:  2014-04-21       Impact factor: 3.240

Review 10.  Management of pulmonary vasodilator therapy in patients with pulmonary arterial hypertension during critical illness.

Authors:  Katie M Muzevich; Hadi Chohan; Daniel C Grinnan
Journal:  Crit Care       Date:  2014-10-07       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.